Business Description
ASLAN Pharmaceuticals Ltd
ISIN : US04522R1014
Share Class Description:
ASLN: ADRDescription
ASLAN Pharmaceuticals Ltd is a clinical-stage immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease. The Company's major business is research and development and operates only in one single segment.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.79 | |||||
| Equity-to-Asset | -0.54 | |||||
| Debt-to-Equity | -2.02 | |||||
| Debt-to-EBITDA | -0.68 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -22.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -6.1 | |||||
| 3-Year EPS without NRI Growth Rate | -12.5 | |||||
| 3-Year FCF Growth Rate | -13.1 | |||||
| 3-Year Book Growth Rate | 15.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.83 | |||||
| 9-Day RSI | 39.54 | |||||
| 14-Day RSI | 42.1 | |||||
| 6-1 Month Momentum % | -51.76 | |||||
| 12-1 Month Momentum % | -86.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.84 | |||||
| Quick Ratio | 1.84 | |||||
| Cash Ratio | 1.62 | |||||
| Days Sales Outstanding | 365 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28 | |||||
| Shareholder Yield % | 15.45 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -363.85 | |||||
| Net Margin % | -368.49 | |||||
| FCF Margin % | -388.75 | |||||
| ROE % | -2114.33 | |||||
| ROA % | -89.89 | |||||
| ROIC % | -417.77 | |||||
| ROC (Joel Greenblatt) % | -4466.52 | |||||
| ROCE % | -140.88 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.61 | |||||
| EV-to-EBIT | -0.39 | |||||
| EV-to-EBITDA | -0.39 | |||||
| EV-to-Revenue | 1.31 | |||||
| EV-to-Forward-Revenue | 2.71 | |||||
| EV-to-FCF | -0.34 | |||||
| Earnings Yield (Greenblatt) % | -256.41 | |||||
| FCF Yield % | -461.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ASLN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ASLAN Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 12 | ||
| EPS (TTM) ($) | -2.615 | ||
| Beta | 0.57 | ||
| Volatility % | 82.52 | ||
| 14-Day RSI | 42.1 | ||
| 14-Day ATR ($) | 0.072054 | ||
| 20-Day SMA ($) | 0.488485 | ||
| 12-1 Month Momentum % | -86.74 | ||
| 52-Week Range ($) | 0.392 - 4.69 | ||
| Shares Outstanding (Mil) | 22.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ASLAN Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ASLAN Pharmaceuticals Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
ASLAN Pharmaceuticals Ltd Frequently Asked Questions
What is ASLAN Pharmaceuticals Ltd(ASLN)'s stock price today?
The current price of ASLN is $0.45. The 52 week high of ASLN is $4.69 and 52 week low is $0.39.
When is next earnings date of ASLAN Pharmaceuticals Ltd(ASLN)?
The next earnings date of ASLAN Pharmaceuticals Ltd(ASLN) is 2024-08-09 Est..
Does ASLAN Pharmaceuticals Ltd(ASLN) pay dividends? If so, how much?
ASLAN Pharmaceuticals Ltd(ASLN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers